Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer-Reference-Cited by-同舟云学术

Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer

Published:2022-11-27 Issue:3 Volume:197 Page:547-558
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Rosenberg Shoshana M.^ORCID,Zheng Yue,Gelber Shari,Ruddy Kathryn J.,Poorvu Philip,Sella Tal,Tamimi Rulla M.,Wassermann Johanna,Schapira Lidia,Borges Virginia F.,Come Steven,Peppercorn Jeffrey,Sepucha Karen R.,Partridge Ann H.

Funder

Susan G. Komen

Breast Cancer Research Foundation

Agency for Healthcare Research and Quality

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06810-1.pdf

Reference31 articles.

1. Fredholm H, Magnusson K, Lindstrom LS, Garmo H, Falt SE, Lindman H, Bergh J, Holmberg L, Ponten F, Frisell J, Fredriksson I (2016) Long-term outcome in young women with breast cancer: a population-based study. Breast Cancer Res Treat 160(1):131–143. https://doi.org/10.1007/s10549-016-3983-9

2. Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM (2016) Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol 34(27):3308–3314. https://doi.org/10.1200/JCO.2015.65.8013

3. Early Breast Cancer Trialists’ Collaborative G (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386(10001):1341–1352. https://doi.org/10.1016/S0140-6736(15)61074-1

4. Early Breast Cancer Trialists’ Collaborative G, Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771–84. https://doi.org/10.1016/S0140-6736(11)60993-8

5. Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW (2012) Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 134(2):459–478. https://doi.org/10.1007/s10549-012-2114-5

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer;The Breast;2024-10

2. Impact of Motivational Interviewing on Psychosocial and Symptom Outcomes During Breast Cancer Endocrine Therapy;2024-09-03

3. Social Characteristics and Adherence to Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer;Journal of Clinical Oncology;2024-06-25

4. Follow-up Routines Matter for Adherence to Endocrine Therapy in the Adjuvant Setting of Breast Cancer;Breast Cancer: Basic and Clinical Research;2024-01

5. The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study;Clinical & Experimental Metastasis;2023-11-02